Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls—a pilot study

Rationale In premenstrual dysphoric disorder (PMDD), a condition that afflicts 3–8 % of women in fertile ages, the cyclic recurrence of debilitating mood symptoms is restricted to the luteal phase of the menstrual cycle. The progesterone metabolite allopregnanolone is produced by the corpus luteum,...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Psychopharmacology Ročník 233; číslo 11; s. 2109 - 2117
Hlavní autoři:	Timby, Erika, Bäckström, Torbjörn, Nyberg, Sigrid, Stenlund, Hans, Wihlbäck, Anna-Carin N., Bixo, Marie
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Berlin/Heidelberg Springer Berlin Heidelberg 01.06.2016 Springer Springer Nature B.V
Témata:	Adolescent Adult Anxiety - psychology Biomedical and Life Sciences Biomedicine Complications and side effects Drug interactions Electrooculography Female GABA GABA Modulators - pharmacology Gonadal Steroid Hormones - blood Gonadal Steroid Hormones - pharmacology Humans Hypnotics and Sedatives - pharmacology Medical disorders Menstrual cycle Menstrual Cycle - drug effects Menstruation Neurosciences Neurosteroid Observations Original Investigation Panic - drug effects Pharmacology/Toxicology Physiological aspects Pilot Projects Pregnanolone - blood Pregnanolone - pharmacology Premenstrual dysphoric disorder Premenstrual Dysphoric Disorder - physiopathology Premenstrual syndrome Psychiatry Psychopharmacology Receptors, GABA-A - drug effects Saccades - drug effects Saccadic eye velocity Steroids Steroids (Drugs) Young Adult GABA Saccadic eye velocity Neurosteroid Menstrual cycle Premenstrual dysphoric disorder
ISSN:	0033-3158, 1432-2072, 1432-2072
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!